References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223
Perkovic V, Huxley R, Wu Y, Prabhakaran D, MacMahon S (2007) The burden of blood pressure-related disease: a neglected priority for global health. Hypertension 50:991–997
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al (2007) 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187
Bakris GL, Townsend RR, Liu M, Cohen SA, D’Agostino R, Flack JM et al (2014) Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3. J Am Coll Cardiol 64:1071–1078
Patel HC, Dhillon PS, Mahfoud F, Lindsay AC, Hayward C, Ernst S et al (2014) The biophysics of renal sympathetic denervation using radiofrequency energy. Clin Res Cardiol 103:337–344
Dörr O, Ewen S, Liebetrau C, Möllmann H, Gaede L, Linz D et al (2015) Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation. Clin Res Cardiol 104:1064–1071
Vogel B, Kirchberger M, Zeier M, Stoll F, Meder B, Saure D et al (2014) Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol 103:117–124
Krum H, Schlaich M, Whitboum R, Sobotka PA, Sadowski J, Bartus K et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of principle cohort study. Lancet 373:1275–1281
Krum H, Barman N, Schlaich M, Sobotka P, Esler M, Mahfoud F, Symplicity HTN-1 Investigators et al (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911–917
Krum H, Schlaich M, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K et al (2014) Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 383:622–629
Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903–1909
Bhatt DL, Kandzari DE, O’Neil WW, D’Agostino R, Flack JM, Katzen BT, Symplicity HTN-3 Investigators et al (2014) A controlled trial of renal denervation for resistant hypertension, Simplicity HTN-3. N Engl J Med 370:1393–1401
Dörr O, Liebetrau C, Möllmann H, Mahfoud F, Ewen S, Gaede L et al (2015) Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension. Clin Res Cardiol 104:175–184
Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D et al (2015) Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis. Clin Res Cardiol 104:1097–1105
Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM et al (2016) Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Clin Res Cardiol 105:364–371
Schroeter MR, Koziolek M (2014) Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach. Clin Res Cardiol 103:79–81
Pöss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C et al (2015) Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension. Clin Res Cardiol 104:672–678
Pöss J, Mahfoud F, Ukena C, Esler MD, Schlaich M, Hering D et al (2014) Association of vitamin D status and blood pressure response after renal denervation. Clin Res Cardiol 103:41–47
Hilbert S, Rogge C, Papageorgiou P, Hindricks G, Bollmann A (2015) Successful single-sided renal denervation in drug-resistant hypertension and ventricular tachycardia. Clin Res Cardiol 104:279–281
Scholz EP, Raake P, Thomas D, Vogel B, Katus HA, Blessing E (2015) Rescue renal sympathetic denervation in a patient with ventricular electrical storm refractory to endo- and epicardial catheter ablation. Clin Res Cardiol 104:79–84
Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C et al (2012) Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol 101:63–67
Scholz EP, Raake P, Thomas D, Vogel B, Katus HA, Blessing E (2015) Rescue renal sympathetic denervation in a patient with ventricular electrical storm refractory to endo- and epicardial catheter ablation: response to comments by Huang et al. Clin Res Cardiol 104:194–195
Linz D, van Hunnik A, Ukena C, Ewen S, Mahfoud F, Schirmer SH et al (2014) Renal denervation: effects on atrial electrophysiology and arrhythmias. Clin Res Cardiol 103:765–774
Ott C, Harazny JM, Schmid A, Ditting T, Veelken R, Bladowski M et al (2015) Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients. Clin Res Cardiol 104:782–789
Huang B, Scherlag BJ, Yu L, Lu Z, He B, Jiang H (2015) Renal sympathetic denervation for treatment of ventricular arrhythmias: a review on current experimental and clinical findings. Clin Res Cardiol 104:535–543
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prado, J.C., Salado, D., Ruilope, L.M. et al. Second denervation in a patient with resistant hypertension. Clin Res Cardiol 105, 880–883 (2016). https://doi.org/10.1007/s00392-016-0997-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-016-0997-6